Diamyd Medical AB (publ) (STO:DMYD.B)
Sweden
· Delayed Price · Currency is SEK 9.62
-0.26 (-2.63%)
At close: Dec 5, 2025
Diamyd Medical AB Revenue
In the fiscal year ending August 31, 2025, Diamyd Medical AB had annual revenue of 130.00K SEK. Diamyd Medical AB had revenue of 19.00K in the quarter ending August 31, 2025, with 5.56% growth.
Revenue
130.00K
Revenue Growth
n/a
P/S Ratio
10,174.98
Revenue / Employee
3.33K
Employees
39
Market Cap
1.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2025 | 130.00K | - | - |
| Aug 31, 2024 | 130.00K | -416.00K | -76.19% |
| Aug 31, 2023 | 546.00K | 92.00K | 20.26% |
| Aug 31, 2022 | 454.00K | 201.00K | 79.45% |
| Aug 31, 2021 | 253.00K | -88.00K | -25.81% |
| Aug 31, 2020 | Pro | Pro | Pro |
| Aug 31, 2019 | Pro | Pro | Pro |
| Aug 31, 2018 | Pro | Pro | Pro |
| Aug 31, 2017 | Pro | Pro | Pro |
| Aug 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 27.85B |
| Getinge AB | 35.85B |
| Sectra AB | 3.37B |
| Camurus AB | 2.35B |
| Medicover AB | 25.67B |
| Asker Healthcare Group AB | 16.41B |
| BioArctic AB | 1.92B |
| AddLife AB | 10.53B |
Diamyd Medical AB News
- 21 days ago - Diamyd Medical AB (publ) (DYMDF) Panel Discussion on Advances and Challenges in Type 1 Diabetes for World Diabetes Day Transcript - Seeking Alpha